Literature DB >> 19452396

Therapy of hypoventilation.

Salman R Khan1, Patrick J Strollo.   

Abstract

Hypoventilation can present as the primary manifestation or as a part of the clinical spectrum in a variety of diseases. It often goes unrecognized by clinicians and health care providers, especially if the presentation is subacute. If untreated, it is associated with increased morbidity and mortality. Some of the consequences of hypoventilation (e.g., cor pulmonale and pulmonary hypertension) may be irreversible. It becomes imperative that conditions commonly associated with hypoventilation (e.g., obesity hypoventilation syndrome, muscular dystrophy, and rigid chest wall diseases) be carefully evaluated and appropriate treatment implemented to prevent these complications. The ability to ventilate patients without invasive procedures is now available. These noninvasive therapies can be successfully implemented and are tolerated well by patients. The noninvasive positive pressure ventilation not only improves nocturnal hypoventilation during sleep but may improve muscle strength during the daytime. This review provides an overview of the treatment of hypoventilation in various diseases with emphasis on noninvasive positive pressure therapy. Treatment needs to be individualized to a given patient and the primary pathology. Success is impacted by the experience of the respiratory team caring for the patient.

Entities:  

Mesh:

Year:  2009        PMID: 19452396     DOI: 10.1055/s-0029-1222444

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  1 in total

1.  Frequency and predictors of obesity hypoventilation in hospitalized patients at a tertiary health care institution.

Authors:  Yilmaz Bülbül; Sibel Ayik; Tevfik Ozlu; Asim Orem
Journal:  Ann Thorac Med       Date:  2014-04       Impact factor: 2.219

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.